Drug Discoveries & Therapeutics
Online ISSN : 1881-784X
Print ISSN : 1881-7831
ISSN-L : 1881-7831

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Relaxation of all-case reporting of COVID-19 cases in Japan
Kenji Karako
著者情報
キーワード: COVID-19, all-case reporting, Japan
ジャーナル フリー 早期公開

論文ID: 2022.01073

この記事には本公開記事があります。
詳細
抄録

Japan is facing the largest outbreak of COVID-19 in history in 2022. The number of new infections per day surpassed 200,000 for the first time in July and peaked in August. Japan has required the reporting of information on all infected persons, but maintaining this system is difficult. Starting in September 2, 2022, four prefectures have implemented a trial policy to limit the infected that must be reported in order to reduce the burden on medical personnel. The policy obliges medical facilities to report only people with a high-risk infection, but the number of the infected will continue to be counted regardless of whether they have a high-risk or low-risk infection. More prefectures are expected to adopt this policy in the future.

著者関連情報
© 2022 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
feedback
Top